Leukocyte Cell Population Analysis From the Coulter Automatic Blood Cell Analyzer DxH800 to Monitor the Effect of G‐CSF

Granulocyte colony‐stimulating factor (G‐CSF) induces the formation of toxic granulation neutrophils (TGNs), which are found in many inflammatory responses. Cell population data (CPD) may be able to clarify the effect of G‐CSF, and potentially help doctors in discriminating the effect of G‐CSF from other inflammatory situations.

[1]  F. Chaves,et al.  Neutrophil volume distribution width: a new automated hematologic parameter for acute infection. , 2009, Archives of pathology & laboratory medicine.

[2]  F. Chaves,et al.  Quantitative determination of neutrophil VCS parameters by the Coulter automated hematology analyzer: new and reliable indicators for acute bacterial infection. , 2005, American journal of clinical pathology.

[3]  Y. Kanakura,et al.  Induction of toxic granulation in neutrophils by granulocyte colony‐stimulating factor , 2002, European journal of haematology.

[4]  Y. Kanakura,et al.  Movement of toxic granulation neutrophils and C-reactive protein in inflammatory processes. , 2002, The American journal of medicine.

[5]  Robert V Pierre,et al.  Peripheral blood film review. The demise of the eyecount leukocyte differential. , 2002, Clinics in laboratory medicine.

[6]  P. Cornbleet Clinical utility of the band count. , 2002, Clinics in laboratory medicine.

[7]  G. Dini,et al.  Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial. , 2002, Haematologica.

[8]  M. Beksac,et al.  Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation , 2001, Bone Marrow Transplantation.

[9]  J. Armitage,et al.  A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. , 2000, Blood.

[10]  T. Kumakawa,et al.  Levels of serum granulocyte colony-stimulating factor in patients with infections. , 1990, Blood.

[11]  T. Fujisawa,et al.  Studies of Peripheral Blood Toxic Neutrophils as a Predictor of Coronary Risk in Kawasaki Disease—the Pathogenetic Role of Hematopoietic Colony‐Stimulating Factors (GM‐CSF, G‐CSF) , 1990, Acta paediatrica Japonica : Overseas edition.

[12]  S. Greenfield,et al.  The complete blood count and leukocyte differential count. An approach to their rational application. , 1987, Annals of internal medicine.

[13]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[14]  J. Gabrilove,et al.  Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells , 1985, The Journal of experimental medicine.